ArticleVisual computing for industry, biomedicine, and art2026
Foundation model for screening severe mitral regurgitation and severe aortic stenosis from coronary angiograms.
Article in Visual computing for industry, biomedicine, and art, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Coronary heart disease (CAD) is the leading cause of death worldwide, and coronary angiography (CAG) serves as the gold standard for its assessment. Valvular heart diseases, such as severe aortic stenosis (AS) and severe mitral regurgitation (MR), frequently coexist with CAD yet are often underdiagnosed. Opportunistic screening for these conditions at the time of CAG could influence therapeutic strategies and improve prognosis. This study developed and validated a foundation model for the automated screening of severe AS and severe MR from CAG videos. The study presents CAGFound, a video-based foundation model that was self-supervised pre-trained on CAG sequences from seven medical centers and subsequently adapted to two downstream tasks: screening for severe AS and severe MR. Two internal and external validation datasets were retrospectively enrolled from the First Medical Center and the Sixth Medical Center of Chinese PLA General Hospital, respectively. A total of 117,383 unlabeled CAG sequences were used to build CAGFound. For the detection of severe AS, CAGFound achieved an area under the receiver operating characteristic curve (AUROC) of 0.932 (sensitivity 0.767, specificity 0.921) on the internal test dataset and maintained robust performance on the external validation dataset, with an AUROC of 0.879 (sensitivity 0.800, specificity 0.955). For the detection of severe MR, the model demonstrated an AUROC of 0.933 (sensitivity 0.738, specificity 0.938) on the internal dataset and an AUROC of 0.896 (sensitivity 0.754, specificity 0.855) on the external cohort. The performance of CAGFound was also compared with other video-based foundation models, VideoMAEv2 and Video Swin. CAGFound achieved the highest AUROC and demonstrated the best calibration performance (Brier score 0.122, R
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.